Healthcare -
Biotechnology - NASDAQ - US
$ 3.94
2.07 %
$ 278 M
Market Cap
-2.42
P/E
CCCC - CASH & EQUIVALENTS
Cash & Equivalents CCCC - C4 Therapeutics, Inc.
127 M
LAST VALUE
28.96%
2 YEAR CAGR
28.37%
5 YEAR CAGR
0.00%
10 YEAR CAGR